# Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

> **NCT06392711** · PHASE1 · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 36 (estimated)

## Conditions studied

- Xerostomia
- Graft-versus-host-disease
- Sjogren's Disease

## Interventions

- **BIOLOGICAL:** Mesenchymal Stromal Cells (MSC) Dose Level 0
- **BIOLOGICAL:** Mesenchymal Stromal Cells (MSC) Dose Level 1

## Key facts

- **NCT ID:** NCT06392711
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392711, "Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06392711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*